Immune Engineering - from Molecules to Therapeutic Approaches
The German Society for Biochemistry and Molecular Biology (GBM e.V.) and the BioPharma Cluster South Germany teamed up for their 2nd joint event on December 1st, 2023, at the "Stadthaus" in Ulm: With focus on translational research in Immune Engineering, you have the opportunity to participate in lectures from academia and industry, a panel discussion followed by networking with fingerfood and drinks – Participation is free of charge, but places are limited. Registration is mandatory and possible until November 24th.
This year, GBM and BioPharma Cluster South Germany will focus on translational research in Immune Engineering, covering basic research, drug development and manufacturing, and clinical application. The patients' perspective will also be addressed in the panel discussion. The target audience is researchers, developers and engineers from industry and academia, young scientists, physicians, and anyone who would like to have a look at the big picture of what we do for patients with our contributions in research, engineering, manufacturing, analytical testing and clinical application.
At the end of the event, we offer all participants the opportunity for exchange and networking with finger food and drinks.
The participation is free of charge, registration is mandatory, and places are limited.
For more information on the program and for registration please visit
https://immune-engineering.gbm-online.de
We look forward to meeting you in Ulm!
Weitere Informationen:
https://immune-engineering.gbm-online.de Website of the event
Die semantisch ähnlichsten Pressemitteilungen im idw
